A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG

Scandinavian Cardiovascular Journal

Volumn 44, Issue 1, 2010, Pages 45-58

  Svedjeholm, Rolf ^a   Vidlund, Mårten ^a   Vanhanen, Ingemar ^a   Håkanson, Erik ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Coronary artery bypass surgery; Glucose insulin potassium; Glutamate; Inotropic agents; Left ventricular dysfunction

Indexed keywords

ADRENALIN; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DOBUTAMINE; DOPAMINE; GLUCOSE; GLUTAMIC ACID; HEPARIN; INOTROPIC AGENT; INSULIN; MORPHINE; NITRATE; NITROPRUSSIDE SODIUM; NORADRENALIN; PANCURONIUM BROMIDE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM; PROTAMINE; SCOPOLAMINE; VASOCONSTRICTOR AGENT; CARDIOPLEGIC AGENT; CARDIOTONIC AGENT; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CIRCULATION; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; ECG ABNORMALITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PHYSIOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL TIME; THORAX PAIN; URINE VOLUME; VENOUS OXYGEN TENSION; COMPLICATION; CONVALESCENCE; ENERGY METABOLISM; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SWEDEN; TIME; TREATMENT OUTCOME;

AGED; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; ENERGY METABOLISM; FEMALE; GLUCOSE; GLUTAMIC ACID; HEART FAILURE; HUMANS; INSULIN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OXYGEN CONSUMPTION; POTASSIUM; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 76649128076     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017430903531008     Document Type: Article

References (71)

1. O'Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birkmeyer NJ, et al.. Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 1998;66:1323-1328
2. Vanky F, Hakanson E, Maros T, Svedjeholm R. Different characteristics of postoperative heart failure after surgery for aortic stenosis and coronary disease. Scand Cardiovasc J. 2004;38:152-158
3. Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology. 1985;62:107-114
4. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross Jr J, et al.. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971; 43:67-82.
5. Khoynezhad A, Jalali Z, Tortolani AJ. Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon. Ann Thorac Surg. 2004;78:1109-1118
6. Royster RL, Butterworth JFt, Prough DS, Johnston WE, Thomas JL, Hogan PE, et al.. Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg. 1991;72:729-736
7. McKinlay KH, Schinderle DB, Swaminathan M, Podgoreanu MV, Milano CA, Messier RH, et al.. Predictors of inotrope use during separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004;18:404-408
8. Goor DA, Golan M, Bar-El Y, Modan M, Lusky A, Rozenman J, et al.. Synergism between infarct-borne left ventricular dysfunction and cardiomegaly in increasing the risk of coronary bypass surgery. J Thorac Cardiovasc Surg. 1992;104:983-989
9. Hochberg MS, Parsonnet V, Gielchinsky I, Hussain SM. Coronary artery bypass grafting in patients with ejection fractions below forty percent. Early and late results in 466 patients. J Thorac Cardiovasc Surg. 1983;86:519-527
10. Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE, Goldman BS, et al.. Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. J Thorac Cardiovasc Surg. 1992;103:1083-91; Discussion 91-92
11. Yau TM, Fedak PWM, Weisel RD, Teng C, Ivanov J. Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. J Thorac Cardiovasc Surg. 1999;118:1006-1013
12. O'Keefe JH, Jr., Allan JJ, McCallister BD, McConahay DR, Vacek JL, Piehler, et al.. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fractionor 40%. Am J Cardiol. 1993; 71:897-901.
13. Soliman Hamad MA, Tan MESH, Van Straten AHM, Van Zundert AAJ, Schonberger JPAM. Long-term results of coronary artery bypass grafting in patients with left ventricular dysfunction. Ann Thorac Surg. 2008;85:488-493
14. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al.. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785-795
15. Thillis GS, Zehr KJ, Williams AW, Schaff HV, Orzulak TA, Daly RC, et al.. Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: Renal function and mortality after 3.8 years. Circulation. 2006;114(1 Suppl):I414-I419.
16. Elefteriades JA, Morales DL, Gradel C, Tollis G, Jr., Levi E, Zaret BL. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions-or 30%. Am J Cardiol. 1997;79:1573-1578
17. Di Carli MF, Maddahi J, Rokhsar S, Schelbert HR, Bianco-Batlles D, Brunken RC, et al.. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997-1004.
18. Kawachi K, Kitamura S, Hasegawa J, Kawata T, Kobayashi S, Mizuguchi K, et al.. Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle. J Cardiovasc Surg. 1997;38:501-505
19. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJT. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298-1304
20. Ascione R, Narayan P, Rogers CA, Lim KH, Capoun R, Angelini GD. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg. 2003;76:793-799
21. Appoo J, Norris C, Merali S, Graham MM, Koshal A, Knudtson ML, et al.. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation. 2004;110(11 Suppl 1): II13-7.
22. Milano CA, White WD, Smith LR, Jones RH, Lowe JE, Smith PK, et al.. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 1993;56:487-493
23. Langenburg SE, Buchanan SA, Blackbourne LH, Scheri RP, Sinclair KN, Martinez J, et al.. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg. 1995:1193-1196
24. Christenson JT, Maurice J, Simonet F, Bloch A, Fournet PC, Velebit V, et al.. Effect of low left ventricular ejection fractions on the outcome of primary coronary by-pass grafting in end-stage coronary artery disease. J Cardiovasc Surg. 1995;36:45-51.
25. Baumgartner FJ, Omari BO, Goldberg S, Pandya AB, Daland AM, Sun S, et al.. Coronary artery bypass grafting in patients with profound ventricular dysfunction. Tex Heart Inst J. 1998;25:125-129
26. Bouchart F, Tabley A, Litzler PY, Haas-Hubscher C, Bessou JP, Soyer R. Myocardial revascularization in patients with severe ischemic left ventricular dysfunction. Long term follow-up in 141 patients. Eur J Cardiothorac Surg. 2001; 20:1157-1162
27. DeRose JJJ, Toumpoulis IK, Balaram SK, Ioannidis JP, Belsley S, Ashton JRC, et al.. Preoperative prediction of longterm survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. J Thorac Cardiovasc Surg. 2005;129:314-321
28. Dietl CA, Berkheimer MD, Woods EL, Gilbert CL, Pharr WF, Benoit CH. Effi cacy and cost-effectiveness of preoperative IABP in patients with ejection fraction of 0.25 or less. Ann Thorac Surg. 1996;62:489-494
29. Lansman SL, Cohen M, Galla JD, Machac J, Quintana CS, Ergin MA, et al.. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Long-term followup. Ann Thorac Surg. 1993;56:480-485
30. Kaul TK, Agnihotri AK, Fields BL, Riggins LS, Wyatt DA, Jones CR. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg. 1996;111:1001-1012
31. Mickleborough LL, Carson S, Tamariz M, Ivanov J. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg. 2000;119:550-557
32. Chan RKM, Raman J, Lee KJ, Rosalion A, Hicks RJ, Pornvilawan S, et al.. Prediction of outcome after revascularization in patients with poor left ventricular function. Ann Thorac Surg. 1996;61:1428-1434
33. Moshkovitz Y, Sternik L, Paz Y, Gurevitch J, Feinberg MS, Smolinsky AK, et al.. Primary coronary artery bypass grafting without cardiopulmonary bypass in impaired left ventricular function. Ann Thorac Surg. 1997;63:S44-7.
34. Shah PJ, Hare DL, Raman JS, Gordon I, Chan RK, Horowitz JD, et al.. Survival after myocardial revascularization for ischemic cardiomyopathy: A prospective ten-year followup study. J Thorac Cardiovasc Surg. 2003;126:1320-1327
35. Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998;66:1632-1639
36. Luciani GB, Montalbano G, Casali G, Mazzucco A. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2000;120:478-489
37. Tan J, Kejriwal N, Vasudevan A, Maria PLS, Alvarez JM. Coronary bypass surgery for patients with chronic poor preoperative left ventricular function (EF - 30%): 5-year follow-up. Heart Lung Circulation. 2006;15:130-136
38. Shapira OM, Hunter CT, Anter E, Bao Y, DeAndrade K, Lazar HL, et al.. Coronary artery bypass grafting in patients with severe left ventricular dysfunction - Early and mid-term outcomes. J Cardiac Surg. 2006;21:225-232
39. Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Kini AS, Adams DH. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg. 2007;84:808-816
40. Svedjeholm R, Huljebrant I, Hakanson E, Vanhanen I. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg. 1995;59:S23-30.
41. Svedjeholm R, Dahlin LG, Lundberg C, Szabo Z, Kagedal B, Nylander E, et al.. Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery? Eur J Cardiothorac Surg. 1998;13:655-661
42. Andersson LG, Ekroth R, Bratteby LE, Hallhagen S. Acute renal failure after coronary surgery - a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg. 1993;41:237-241
43. Smith RC, Leung JM, Mangano DT. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. S.P.I. Research Group. Anesthesiology. 1991; 74:464-473
44. Hakanson E, Svedjeholm R, Vanhanen I. Physiologic aspects in postoperative cardiac patients. Ann Thorac Surg. 1995;59: S12-4.
45. Svedjeholm R, Hakanson E, Szabo Z. Routine SvO 2 measuremenTafter CABG surgery with a surgically introduced pulmonary artery catheter. Eur J Cardiothorac Surg. 1999; 16:450-457
46. Szabo Z, Hakanson E, Maros T, Svedjeholm R. High-dose glucose-insulin-potassium after cardiac surgery: A retrospective analysis of clinical safety issues. Acta Anaesthesiol Scand. 2003;47:383-390
47. Svedjeholm R, Hakanson E, Szabo Z, Vanky F. Neurological injury after surgery for ischemic heart disease: Risk factors, outcome and role of metabolic interventions. Eur J Cardiothorac Surg. 2001:611-618
48. Cimochowski GE, Harostock MD, Foldes PJ. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg. 1997;113:655-664
49. Svedjeholm R, Hallhagen S, Ekroth R, Joachimsson PO, Ronquist G. Dopamine and high-dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: Effects on myocardial metabolism. Ann Thorac Surg. 1991;51: 262-270
50. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-tobedside review: Inotropic drug therapy after adult cardiac surgery-a systematic literature review. Crit Care 2005;9: 266-279
51. Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: A comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth. 1992;6:542-553
52. Angelini A, Maiolino G, La Canna G, Ceconi C, Calabrese F, Pettenazzo E, et al.. Relevance of apoptosis in influencing recovery of hibernating myocardium. Eur J Heart Fail. 2007;9:377-383
53. Antunes PE, De Oliveira JMF, Antunes MJ. Coronary surgery with non-cardioplegic methods in patients with advanced left ventricular dysfunction: Immediate and long term results. Heart. 2003;89:427-431
54. Trehan N, Khanna SN, Mishra Y, Kohli V, Mehta Y, Mishra M, et al.. Predictors of early outcome after coronary artery surgery in patients with severe left ventricular dysfunction. J Card Surg. 2003;18:101-106
55. Fergusson DA, Hebert PC, Mazer CD, Fremes S, Mac Adams C, Murkin JM, et al.. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-2331
56. Yusuf S TK. Inotropic agents increase mortality in patients with congestive heart failure. Circulation. 1990;82 (Suppl III): 673.
57. Thiesmayr M, Haider WJ, Grubhofer G, Heilinger D, Keznickl FP, Mares P, et al.. Effects of dobutamine versus insulin on cardiac performance, myocardial oxygen demand, and total body metabolism after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 1995;9:653-658
58. Svedjeholm R, Ekroth R, Joachimsson PO, Tyden H. High-dose insulin improves the effi cacy of dopamine early after cardiac surgery. A study of myocardial performance and oxygen consumption. Scand J Thorac Cardiovasc Surg. 1991; 25:215-221
59. Svedjeholm R, Vanhanen I, Hakanson E, Joachimsson PO, Jorfeldt L, Nilsson L. Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations. J Thorac Cardiovasc Surg. 1996;112:1468-1477
60. Gradinac S, Coleman GM, Taegtmeyer H, Sweeney MS, Frazier OH. Improved cardiac function with glucose-insulinpotassium after aortocoronary bypass grafting. Ann Thorac Surg. 1989;48:484-489
61. Pisarenko OI, Lepilin MG, Ivanov VE. Cardiac metabolism and performance during L-glutamic acid infusion in postoperative cardiac failure. Clin Sci. 1986;70:7-12.
62. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150
63. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997;113:354-360
64. Zhang HF, Fan Q, Qian XX, Lopez BL, Christopher TA, Ma XL, et al.. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis. 2004;9:777-783
65. Nordhaug D Stenseth R, Wahba A, Sellevold O.F, Karevold R, Astudillo R, et al.. Levosimendan in high-risk cardiac surgery. http://www.scandinavian-ats. org/documents/ PDF/61.pdf Scandinavian Association for Thoracic Surgery, Annual meeting; Reykjavik, Iceland; 2006.
66. Lazar HL, Buckberg GD, Foglia RP, Manganaro AJ, Maloney JV, Jr. Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;82:18-25.
67. Vanhanen I, Hakanson E, Jorfeldt L, Svedjeholm R. Intravenous aspartate infusion after a coronary operation: Effects on myocardial metabolism and hemodynamic state. Ann Thorac Surg. 1998;65:1296-1302
68. Jeppsson A, Ekroth R, Kirno K, Milocco I, Nilsson B, Nilsson F, et al.. Insulin and amino acid infusion after cardiac operations: Effects on systemic and renal perfusion. J Thorac Cardiovasc Surg. 1997;113:594-602.
69. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Brit J Anaesth. 1997;78: 606-617
70. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, et al.. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112(9 Suppl):I344-50.
71. Shapira I, Isakov A, Yakirevich V, Topilsky M. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest. 1995;108:1546-1550